Arisymo AI platform (AriOPM) sifts through extensive genomic data, imaging data, biopsy data, microbiome data, and clinical data to pinpoint fresh drug targets for different types of cancers, we predict how patients will respond, tailoring treatments accordingly, thereby reducing toxicity, enhancing bioactivity. While employing blockchain throughout ensures system integrity.